Oruka Therapeutics (ORKA) Enterprise Value Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.35% |
| Dec 31, 2025 | -104.32% |
| Sep 30, 2025 | 13.99% |
| Jun 30, 2025 | -886.71% |
| Mar 31, 2025 | -1,666.86% |
| Dec 31, 2024 | -903.57% |
| Sep 30, 2024 | -947.94% |
| Jun 30, 2024 | 17.12% |
| Mar 31, 2024 | 12.11% |
| Dec 31, 2023 | 11.81% |
| Sep 30, 2023 | 12.41% |
| Jun 30, 2023 | 13.53% |
| Mar 31, 2023 | 16.73% |
| Dec 31, 2022 | 20.45% |
| Sep 30, 2022 | 24.65% |
| Jun 30, 2022 | 26.52% |
| Mar 31, 2022 | 26.70% |
| Dec 31, 2021 | -8.74% |
| Sep 30, 2021 | -14.13% |
| Jun 30, 2021 | -472.38% |
| Mar 31, 2021 | -902.89% |
| Dec 31, 2020 | -486.76% |
| Sep 30, 2020 | -429.76% |
| Jun 30, 2020 | -10.79% |
| Mar 31, 2020 | 16.64% |
| Dec 31, 2019 | -26.56% |
| Sep 30, 2019 | -19.40% |
| Jun 30, 2019 | -3.44% |
| Mar 31, 2019 | 33.81% |
| Dec 31, 2018 | 43.77% |
| Sep 30, 2018 | 49.36% |
| Jun 30, 2018 | 39.81% |
| Mar 31, 2018 | 37.04% |
| Dec 31, 2017 | 44.47% |
| Sep 30, 2017 | 32.03% |
| Jun 30, 2017 | 39.27% |
| Mar 31, 2017 | 37.27% |
| Dec 31, 2016 | 45.46% |
| Sep 30, 2016 | 43.43% |
| Jun 30, 2016 | 40.21% |
| Mar 31, 2016 | -151.37% |
| Dec 31, 2015 | -152.72% |
| Sep 30, 2015 | -140.49% |
| Jun 30, 2015 | -127.52% |
| Mar 31, 2015 | 42.53% |
| Dec 31, 2014 | 8.37% |
| Sep 30, 2014 | 7.42% |
| Jun 30, 2014 | 4.89% |
| Mar 31, 2014 | -499.43% |
| Dec 31, 2013 | -473.84% |
| Sep 30, 2013 | -504.74% |
| Jun 30, 2013 | -540.29% |
| Mar 31, 2013 | 16.32% |
| Dec 31, 2012 | 50.87% |
| Sep 30, 2012 | 46.40% |
| Jun 30, 2012 | 57.36% |
| Mar 31, 2012 | 16.87% |
| Dec 31, 2011 | 15.40% |
| Sep 30, 2011 | 27.30% |
| Jun 30, 2011 | 24.75% |